Skip to main content
SpringerLink
Log in

Chemotherapy for Bladder Cancer in the Elderly

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Joint Committee on Cancer: manual for staging of cancer, pp. 193–199, JB Lippincott & Co, Philadelphia, 1988

  • Anisimov VN. Carcinogenesis and Aging, Vol. I, pp. 1–47, CRC Press, Boca Raton, 1987

    Google Scholar 

  • Armitage JO, Potter JF. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. Journal of the American Geriatrics Society 32: 269–273, 1984

    PubMed  CAS  Google Scholar 

  • Batata MA, Chu FCH, Hilaris BS, Kim YS, Lee MZ, et al. Factors of prognostic and therapeutic significance in patients with bladder cancer. International Journal of Radiation, Oncology, Biology, Physics 7: 575–579, 1981

    Article  CAS  Google Scholar 

  • Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly: the experience of Eastern Cooperative Oncology Group. Cancer 52: 1986–1992, 1982

    Article  Google Scholar 

  • Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GMM, et al. T3 bladder cancer - the case for salvage cystectomy. British Journal of Urology 52: 506–510, 1980

    Article  PubMed  CAS  Google Scholar 

  • Bloom HJG, Hendry WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review. British Journal of Urology 54: 136–151, 1982

    Article  PubMed  CAS  Google Scholar 

  • Bowles LT. Surgical essentials in the care of the elderly cancer patient. In Yancik et al. (Eds) Perspectives on prevention and treatment of cancer in the elderly, pp. 57–61, Raven Press, New York, 1983

    Google Scholar 

  • Cohen HJ. Clinical aspects of cancer in the elderly. In Pullman et al. (Eds) Interrelationship among aging, cancer and differentiation, pp. 15–21, Reidel Publishing Co., Dordrecht, 1985

    Chapter  Google Scholar 

  • Crawford J, Cohen HJ. Relationship of cancer and aging. Clinics in Geriatric Medicine 3: 419–431, 1987

    PubMed  CAS  Google Scholar 

  • Crocker I, Prosnitz L. Radiation therapy of the elderly. Clinics in Geriatric Medicine 3: 473–481, 1987

    PubMed  CAS  Google Scholar 

  • Findlay MPN, Griffin A-M, Raghavan D, McDonald KE, Coates AS, et al. Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means? European Journal of Cancer 27: 1597–1600, 1991

    Article  PubMed  CAS  Google Scholar 

  • Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. New England Journal of Medicine 318: 1414–1422, 1988

    Article  PubMed  CAS  Google Scholar 

  • Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A, et al. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer 67: 1525–1531, 1991

    Article  PubMed  CAS  Google Scholar 

  • Gelman RS, Taylor SG. CNF chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. Journal of Clinical Oncology 2: 1404–1413, 1984

    PubMed  CAS  Google Scholar 

  • Goodwin JS, Samet JN, Key CR, Humble C, Kutvirt D, et al. Stage at diagnoses of cancer varies with the age of the patient. Journal of the American Geriatrics Society 34: 20–26, 1986

    PubMed  CAS  Google Scholar 

  • Gospodarowicz MK, Hawkins NV, Rawlings GA, Connolly JG, Jewett MA, et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. Journal of Urology 142: 1448–1454, 1989

    PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. New England Journal of Medicine 306: 1081–1088, 1982

    Article  PubMed  CAS  Google Scholar 

  • Hansen HH, Selawry OS, Holland JF, McCall CB. The variability of individual tolerance to methotrexate in cancer patients. British Journal of Cancer 25: 298–305, 1971

    Article  PubMed  CAS  Google Scholar 

  • Hillcoat BL, Raghavan D, Matthews J, Kefford R, Yuen K, et al. A randomised trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. Journal of Clinical Oncology 7: 706–709, 1989

    PubMed  CAS  Google Scholar 

  • Holmes FF. Clinical evidence for a change in tumor aggressiveness with age. Seminars in Oncology 16: 34–40, 1989

    PubMed  CAS  Google Scholar 

  • Hrushesky WJ, Shimp W, Kennedy BJ. Lack of age-dependent cisplatin nephrotoxicity. American Journal of Medicine 76: 579–584, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kaesberg PR, Ershler WB. The change in tumor aggressiveness with age: lessons from experimental animals. Seminars in Oncology 16: 28–33, 1989

    PubMed  CAS  Google Scholar 

  • Khandekar JD, Elson PJ, DeWys WD, Slayton RE, Harris DT, et al. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract. Journal of Clinical Oncology 3: 539–545, 1985

    PubMed  CAS  Google Scholar 

  • Koontz WW Jr, Prout GR Jr, Smith W, Frable WJ, Minnis JE. The use of intravesical thiotepa in the management of non-invasive carcinoma of the bladder. Journal of Urology 125: 307–312, 1981

    PubMed  Google Scholar 

  • Koss LG. Tumors of the urinary bladder: atlas of tumor pathology, 2nd series, fascicle 11, Armed Forces Institute of Pathology, Washington, DC, 1975

    Google Scholar 

  • Kurth KH, Schroder FH, Tunn U, Ay R, Pavone-Macaluso M, et al. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European Organization for Research on Treatment of Cancer randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. Journal of Urology 132: 258–262, 1984

    PubMed  CAS  Google Scholar 

  • Lees JC, Park WW. The malignancy of cancer at different ages: a histological study. British Journal of Cancer 3: 186–197, 1950

    Article  Google Scholar 

  • Lindeman RD. Changes in renal function with aging: implications for treatment. Drugs & Aging 2: 423–431, 1992

    Article  CAS  Google Scholar 

  • Loehrer Snr PJ, Einhorn LH, Elson PJ, Tannock I, Raghavan D, et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Journal of Clinical Oncology 10: 1066–1073, 1992

    PubMed  Google Scholar 

  • McLachlan NSF. The aging kidney. Lancet 2: 143–146, 1978

    Article  PubMed  CAS  Google Scholar 

  • Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, et al. Relationship between age at diagnosis and treatments received by cancer patients. Journal of the American Geriatrics Society 33: 585–589, 1985

    PubMed  CAS  Google Scholar 

  • National Cancer Institute, Division of Cancer Prevention and Control. Cancer statistics review: 1973–1986, US Dept of Health and Human Services, Bethesda, NIH Publication 89–2789, pp. III.1–III.53, 1989

  • Niijima T, Koiso K, Akaza H. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer. Cancer Chemotherapy and Pharmacology 11(Suppl.): S79–S82, 1983

    PubMed  Google Scholar 

  • NSW Central Cancer Registry. Cancer in New South Wales: incidence and mortality. 1982, pp. 22–83, Department of Health, Sydney, 1986

  • Patterson WB. Surgical issues in geriatric oncology. Seminars in Oncology 16: 57–65, 1989

    PubMed  CAS  Google Scholar 

  • Peto R, Roe FJC, Lee PN, Levy L, Clack J. Cancer and ageing in mice and men. British Journal of Cancer 32: 411–426, 1975

    Article  PubMed  CAS  Google Scholar 

  • Raghavan D. Preemptive (neoadjuvant) intravenous chemotherapy for invasive bladder cancer. British Journal of Urology 61: 1–8, 1988

    Article  PubMed  CAS  Google Scholar 

  • Raghavan D. Management of advanced bladder cancer in the elderly. Urology Clinics of North America 19: 797–806, 1992

    CAS  Google Scholar 

  • Raghavan D, Pearson B, Duval P, Rogers J, Meagher M, et al. Initial intravenous cis-platinum therapy: improved management for high risk bladder cancer? Journal of Urology 133: 399–402, 1985

    PubMed  CAS  Google Scholar 

  • Raghavan D, Grundy R, Greenaway TM, Pearson BS, Rogers J, et al. Pre-emptive (neoadjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contraindication. British Journal of Urology 62: 154–159, 1988

    Article  PubMed  CAS  Google Scholar 

  • Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. New England Journal of Medicine 322: 1129–1138, 1990

    Article  PubMed  CAS  Google Scholar 

  • Raghavan D, Findlay M, McNeil E. Cancer in the Elderly. In Peckham et al. (Eds), Oxford textbook of oncology, Oxford University Press, in press, 1993

    Google Scholar 

  • Ries LG, Pollack ES, Young JL. Cancer patient survival: surveillance, epidemiology, and end results. Journal of National Cancer Institute 70: 693–707, 1983

    CAS  Google Scholar 

  • Scher HI, Herr H, Sternberg C, Fair W, Bosl G, et al. Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the MVAC regimen. British Journal of Urology 64: 250–256, 1989

    Article  PubMed  CAS  Google Scholar 

  • Sella A, Logothetis CJ, Dexeus FH, Amato R, Finn L, et al. Cisplatin combination chemotherapy for elderly patients with urothelial tumours. British Journal of Urology 67: 603–607, 1991

    Article  PubMed  CAS  Google Scholar 

  • Shaw PG. Common pitfalls in geriatric drug prescribing. Drugs 23: 324–328, 1982

    Article  PubMed  CAS  Google Scholar 

  • Shearer RJ, Chilvers CED, Bloom HJG, Bliss JM, Horwich A, et al. Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. British Journal of Urology 62: 558–564, 1988

    Article  PubMed  CAS  Google Scholar 

  • Skinner EC, Lieskovsky G, Skinner DG. Radical cystectomy in the elderly patient. Journal of Urology 131: 1065–1068, 1984

    PubMed  CAS  Google Scholar 

  • Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. Journal of Urology 145: 459–467, 1991

    PubMed  CAS  Google Scholar 

  • Soloway MS. The management of superficial bladder cancer, with emphasis on intravesical chemotherapy. In Raghavan (Ed.) The management of bladder cancer, pp. 118–139, Edward Arnold, London, 1988

    Google Scholar 

  • Sondik EJ, Young JL, Horm JW. 1986 Annual cancer statistics review, NIH publication no. 877-789, Department of Health and Human Services, Bethesda, 1987

    Google Scholar 

  • Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, et al. MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. Journal of Urology 139: 461–469, 1988

    PubMed  CAS  Google Scholar 

  • Suen KC, Lau LL, Yermakov V. Cancer and old age. An autopsy study of 3,535 patients over 65 years old. Cancer 33: 1164–1168, 1974

    Article  PubMed  CAS  Google Scholar 

  • Torti FM, Lum BL. The biology and treatment of superficial bladder cancer. Journal of Clinical Oncology 2: 505–531, 1983

    Google Scholar 

  • Triggs EJ, Nation RLL. Pharmacokinetics in the aged: a review. Journal of Pharmacokinetics and Biopharmacology 3: 387–418, 1975

    Article  CAS  Google Scholar 

  • Troner M, Birch R, Omura GA, Williams S. Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial. Journal of Urology 137: 660–662, 1987

    PubMed  CAS  Google Scholar 

  • Van der Werf Messing B. Preoperative irradiation followed by cystectomy to treat carcinoma of the urinary bladder category T3NX,0-4M0. International Journal of Radiation, Oncology, Biology, Physics 5: 394–401, 1979

    Google Scholar 

  • Vestal RE. Drug use in the elderly: a review of problems and special considerations. Drugs 16: 358–382, 1978

    Article  PubMed  CAS  Google Scholar 

  • Wallace DMA, Raghavan D, Kelly KA, Sandeman TF, Conn IG, et al. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. British Journal of Urology 67: 608–615, 1991

    Article  PubMed  CAS  Google Scholar 

  • Waxman J, Abel P, James N, Farah N, O’Donoghue EP, et al. New combination chemotherapy programme for bladder cancer. British Journal of Urology 63: 68–71, 1989

    Article  PubMed  CAS  Google Scholar 

  • Woodhouse K, Wynne HA. Age-related changes in hepatic function. Implications for drug therapy. Drugs & Aging 2: 243–255, 1992

    Article  CAS  Google Scholar 

  • Zincke H, Sen SE, Hahn RG, Keating JP. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder? Mayo Clinic Proceedings 63: 16–22, 1988

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Solid Tumor Oncology and Investigational Therapeutics, Department of Medicine, Roswell Park Cancer Institute and State University of New York at Buffalo, Elm & Carlton Sts, Buffalo, New York, 14263, USA

    Derek Raghavan

Authors
  1. Derek Raghavan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raghavan, D. Chemotherapy for Bladder Cancer in the Elderly. Drugs & Aging 3, 1–8 (1993). https://doi.org/10.2165/00002512-199303010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199303010-00001

Keywords

Search

Navigation